Exit Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Exit Wealth Advisors's GILD Position: Q2 2026 in Review
Exit Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.69% in Q2 2026, buying an estimated $1.58K and bringing the position to 1,756 shares worth $222K. The position accounts for 0.1% of the portfolio, ranked #137.
Exit Wealth Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $243K in Q1 2026. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Exit Wealth Advisors held 1,756 shares of Gilead Sciences worth $222K as of Q2 2026.
- Exit Wealth Advisors bought 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
- Gilead Sciences made up 0.1% of Exit Wealth Advisors's portfolio in Q2 2026, its #137 holding.
- Exit Wealth Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
- Exit Wealth Advisors's Gilead Sciences position peaked at $243K in Q1 2026.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Exit Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.